Purchase Order HHSN272201300849P

<p>This is a $11,360.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to RX Biosciences, LLC for the construction of a phage display library. The award was made on October 27, 2015 with a completion date of February 24, 2016. RX Biosciences, LLC is a minority-owned, self-certified small disadvantaged business. The contract has no set-aside designation.</p>

This is a $14,400.00 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Personal Diagnostix Inc., a minority-owned and small disadvantaged business, for Ion Torrent sequencing of RNA virus samples. The contract has an ultimate completion date of April 25, 2013 and does not have a set-aside designation. This contract appears to be for NIAID's research and development activities related to viral diagnostics...

<p>This $23,991.00 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Protein Biosolutions Inc. on May 8, 2014. The contract is for AMBIS # 1678920 SEQUENCING services, with a period of performance ending on June 20, 2014. The contract was not set aside for any specific business type.</p>

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The award, valued at $14,994, is for the delivery of 5,400 crude peptides by A &amp; A LABS LLC, also doing business as Synthetic Biomolecules. The contract does not have a set-aside designation. A &amp; A LABS LLC is a minority-owned, small disadvantaged business. This contract award may support NIAID's...

<p>This is a $4,455 fixed-price level of effort purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Capital Biosciences, Inc. The contract has no set-aside designation and was awarded on February 2, 2011 with a final completion date of September 28, 2015. The place of performance is Rockville, Maryland.</p>

<p>The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,106.04 firm fixed-price purchase order contract to OZ Biosciences USA, Inc. for transduction reagents. This award was set aside for small businesses. The place of performance is San Diego, California. The contract has an August 31, 2018 completion date.</p>

<p>This is a $23,549.66 purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Bio Basic Canada Inc. The contract is for the purchase of synthetic DNA related to respiratory syncytial virus (RSV) research. The contract has a completion date of September 16, 2010 and was awarded on August 17, 2010. This contract is not associated with a set-aside program.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Psomagen Inc. for $10,320.00 on September 15, 2022, for RNA extraction, DNA isolation, and library preparation services under the FY26 UDO Initiative. No set-aside was used. Performance occurs in Rockville, Maryland. The order is firm fixed price and carries an ultimate completion date of October 14, 2022.</p>

<p>The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $12,058.80 firm fixed price purchase order contract to OZ Biosciences USA, Inc. for the provision of transfection reagents. The contract has a total small business set-aside designation and was awarded on August 1, 2017, with an ultimate completion date of August 31, 2017. This appears to be a standalone contract, not associated with a larger contract vehicle.</p>

<p>This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Bioexpress, LLC for $3,710.00. The contract is for laboratory equipment and supplies, with a period of performance ending on June 14, 2015. The contract was competitively awarded and does not have a set-aside designation.</p>